Association of Taurine with In-Hospital Mortality in Patients after Out-of-Hospital Cardiac Arrest: Results from the Prospective, Observational COMMUNICATE Study.

metabolomics mortality out-of-hospital-cardiac arrest prognosis taurine

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
09 May 2020
Historique:
received: 01 05 2020
revised: 01 05 2020
accepted: 05 05 2020
entrez: 14 5 2020
pubmed: 14 5 2020
medline: 14 5 2020
Statut: epublish

Résumé

Studies have suggested that taurine may have neuro- and cardio-protective functions, but there is little research looking at taurine levels in patients after out-of-hospital cardiac arrest (OHCA). Our aim was to evaluate the association of taurine with mortality and neurological deficits in a well-defined cohort of OHCA patients. We prospectively measured serum taurine concentration in OHCA patients upon admission to the intensive care unit (ICU) of the University Hospital Basel (Switzerland). We analyzed the association of taurine levels and in-hospital mortality (primary endpoint). We further evaluated neurological outcomes assessed by the cerebral performance category scale. We calculated logistic regression analyses and report odds ratios (OR) and 95% confidence intervals (CI). We calculated different predefined multivariable regression models including demographic variables, comorbidities, initial vital signs, initial blood markers and resuscitation measures. We assessed discrimination by means of area under the receiver operating curve (ROC). Of 240 included patients, 130 (54.2%) survived until hospital discharge and 110 (45.8%) had a favorable neurological outcome. Taurine levels were significantly associated with higher in-hospital mortality (adjusted OR 4.12 (95%CI 1.22 to 13.91), Admission taurine levels are associated with mortality and neurological outcomes in OHCA patients and may help in the risk assessment of this vulnerable population. Further studies are needed to assess whether therapeutic modulation of taurine may improve clinical outcomes after cardiac arrest.

Sections du résumé

BACKGROUND BACKGROUND
Studies have suggested that taurine may have neuro- and cardio-protective functions, but there is little research looking at taurine levels in patients after out-of-hospital cardiac arrest (OHCA). Our aim was to evaluate the association of taurine with mortality and neurological deficits in a well-defined cohort of OHCA patients.
METHODS METHODS
We prospectively measured serum taurine concentration in OHCA patients upon admission to the intensive care unit (ICU) of the University Hospital Basel (Switzerland). We analyzed the association of taurine levels and in-hospital mortality (primary endpoint). We further evaluated neurological outcomes assessed by the cerebral performance category scale. We calculated logistic regression analyses and report odds ratios (OR) and 95% confidence intervals (CI). We calculated different predefined multivariable regression models including demographic variables, comorbidities, initial vital signs, initial blood markers and resuscitation measures. We assessed discrimination by means of area under the receiver operating curve (ROC).
RESULTS RESULTS
Of 240 included patients, 130 (54.2%) survived until hospital discharge and 110 (45.8%) had a favorable neurological outcome. Taurine levels were significantly associated with higher in-hospital mortality (adjusted OR 4.12 (95%CI 1.22 to 13.91),
CONCLUSION CONCLUSIONS
Admission taurine levels are associated with mortality and neurological outcomes in OHCA patients and may help in the risk assessment of this vulnerable population. Further studies are needed to assess whether therapeutic modulation of taurine may improve clinical outcomes after cardiac arrest.

Identifiants

pubmed: 32397548
pii: jcm9051405
doi: 10.3390/jcm9051405
pmc: PMC7290691
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Gottfried und Julia Bangerter-Rhyner-Stiftung
ID : 8472/ HEG-DSV

Références

Adv Exp Med Biol. 1998;442:501-5
pubmed: 9635067
Nat Genet. 2010 Feb;42(2):137-41
pubmed: 20037589
Postgrad Med. 2018 Nov;130(8):669-672
pubmed: 30321085
Exp Clin Cardiol. 2008 Summer;13(2):57-65
pubmed: 19343117
J Appl Physiol (1985). 2003 Mar;94(3):1122-8
pubmed: 12433868
Lancet. 1975 Mar 1;1(7905):480-4
pubmed: 46957
Resuscitation. 2019 Sep;142:50-60
pubmed: 31306716
Int J Cardiol. 1990 Jun;27(3):361-6
pubmed: 2351495
Eur J Intern Med. 2016 Dec;36:67-73
pubmed: 27567042
Physiol Rev. 1992 Jan;72(1):101-63
pubmed: 1731369
Am J Physiol Cell Physiol. 2004 Oct;287(4):C949-53
pubmed: 15253891
Clin Chem Lab Med. 2016 Nov 1;54(11):1831-1846
pubmed: 27101551
PLoS One. 2015 Apr 07;10(4):e0121933
pubmed: 25849571
Adv Exp Med Biol. 2003;526:41-8
pubmed: 12908582
Aorta (Stamford). 2015 Feb 01;3(1):41-5
pubmed: 26798756
Amino Acids. 2012 Aug;43(2):845-55
pubmed: 22080215
Crit Care Med. 2015 Feb;43(2):503
pubmed: 25599486
N Engl J Med. 2013 Dec 5;369(23):2197-206
pubmed: 24237006
Resuscitation. 2019 Mar;136:21-29
pubmed: 30391369
J Crit Care. 2019 Jun;51:57-63
pubmed: 30745287
J Lab Clin Med. 1981 Dec;98(6):849-59
pubmed: 7310226
J Neurosurg. 2013 Oct;119(4):1021-7
pubmed: 23683074
J Cell Mol Med. 2009 Jun;13(6):1125-35
pubmed: 19602041
N Engl J Med. 2009 Aug 6;361(6):605-11
pubmed: 19657124
Resuscitation. 2016 Aug;105:188-95
pubmed: 27321577
PLoS One. 2016 Apr 13;11(4):e0153672
pubmed: 27073872
Ther Umsch. 2008 Sep;65(9):487-91
pubmed: 18791962
Crit Care. 2017 Mar 24;21(1):72
pubmed: 28335807
Resuscitation. 2018 Sep;130:138-145
pubmed: 30036589
Respir Res. 2015 Oct 15;16:125
pubmed: 26471192
J Nutr. 2000 Sep;130(9):2222-7
pubmed: 10958816
Crit Care. 2010;14(3):R106
pubmed: 20529344
Amino Acids. 2000;19(3-4):509-26
pubmed: 11140356
Mol Med Rep. 2018 Nov;18(5):4516-4522
pubmed: 30221665
J Biophys Biochem Cytol. 1961 Dec;11:607-26
pubmed: 14468625
Neurochem Res. 2004 Jan;29(1):267-74
pubmed: 14992286
Front Neurosci. 2019 Apr 12;13:343
pubmed: 31031585
Annu Rev Med. 2009;60:355-66
pubmed: 19630576

Auteurs

Naemi Herzog (N)

Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland.

Rahel Laager (R)

Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland.

Emanuel Thommen (E)

Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland.

Madlaina Widmer (M)

Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland.

Alessia M Vincent (AM)

Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland.

Annalena Keller (A)

Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland.

Christoph Becker (C)

Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland.
Faculty of Medicine, University of Basel, 4031 Basel, Switzerland.
Emergency Department, University Hospital Basel, 4031 Basel, Switzerland.

Katharina Beck (K)

Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland.

Sebastian Perrig (S)

Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland.

Luca Bernasconi (L)

Institute of Laboratory Medicine, Kantonsspital Aarau, 5000 Aarau, Switzerland.

Peter Neyer (P)

Institute of Laboratory Medicine, Kantonsspital Aarau, 5000 Aarau, Switzerland.

Stephan Marsch (S)

Faculty of Medicine, University of Basel, 4031 Basel, Switzerland.
Department of Intensive Care, University Hospital Basel, 4031 Basel, Switzerland.

Philipp Schuetz (P)

Faculty of Medicine, University of Basel, 4031 Basel, Switzerland.
Department of Internal Medicine, Kantonsspital Aarau, 5000 Aarau, Switzerland.

Raoul Sutter (R)

Faculty of Medicine, University of Basel, 4031 Basel, Switzerland.
Department of Intensive Care, University Hospital Basel, 4031 Basel, Switzerland.
Department of Neurology, University Hospital Basel, 4031 Basel, Switzerland.

Kai Tisljar (K)

Department of Intensive Care, University Hospital Basel, 4031 Basel, Switzerland.

Sabina Hunziker (S)

Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland.
Faculty of Medicine, University of Basel, 4031 Basel, Switzerland.
Department of Intensive Care, University Hospital Basel, 4031 Basel, Switzerland.

Classifications MeSH